The medical oncology research department leads a broad translational cancer research program building from Cabrini being the second largest cancer service in Victoria—and the largest private cancer service in Australia. Our dedicated and experienced team of academic and clinician researchers are invested in translational bench-to-bedside advances in precision medicine.
The research program includes clinical trials assessing the latest advances in therapeutics, the development of preclinical breast and ovarian cancer models to advance biological discovery and identify new therapeutics and targets, cancer exercise laboratory testing to understand the relationship and benefits of exercise in cancer, clinical evaluation of cancer healthcare models, and using health informatics and patient-reported outcome measures to identify ways we can improve the patient experience through better quality of life, less toxicity, and better patient survivorship.
Our program provides significant benefits for patients, including access to treatments not yet in the marketplace, close monitoring and testing, and collection of valuable information that can help others.
Through translational research, we are advancing precision medicine to improve the diagnosis, treatment, management and prevention of cancer.